Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy. [electronic resource]
Producer: 20150618Description: 25-32 p. digitalISSN:- 2325-8179
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Blood Flow Velocity
- Blood Pressure -- physiology
- Central Serous Chorioretinopathy -- diagnosis
- Choroid -- physiopathology
- Chronic Disease
- Coloring Agents
- Female
- Fluorescein Angiography
- Heart Rate
- Humans
- Indocyanine Green
- Intraocular Pressure -- physiology
- Intravitreal Injections
- Laser-Doppler Flowmetry
- Male
- Middle Aged
- Organ Size
- Prospective Studies
- Regional Blood Flow
- Retina -- pathology
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.